Capricor Therapeutics Inc. (CAPR) Financial Statements (2026 and earlier)

Company Profile

Business Address 10865 ROAD TO THE CURE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:318,129151,50039,50041,40034,88532,666
Cash and cash equivalent287,84711,28714,6959,60334,88532,666
Short-term investments30,282140,22924,79331,818  
Other undisclosed cash, cash equivalents, and short-term investments  (16)12(21)  
Receivables 5910,36810,372548392 
Other undisclosed current assets4,7521,5179839411,1601,011
Total current assets:322,940163,38550,85542,88936,43733,677
Noncurrent Assets
Operating lease, right-of-use asset13,5381,3132,0502,3502,822 
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization18,3125,5625,5614,5881,796851
Intangible asset, including goodwill, after accumulated amortization     (260)2
Intangible asset, excluding goodwill, after accumulated amortization     (260)2
Other undisclosed noncurrent assets1,15922226826853589
Total noncurrent assets:33,0107,0967,8797,2064,893942
TOTAL ASSETS:355,949170,48158,73450,09541,33034,619
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:17,2128,1916,2234,8353,1162,725
Accounts payable1,655     
Accrued liabilities15,558     
Other undisclosed accounts payable and accrued liabilities  8,1916,2234,8353,1162,725
Deferred revenue12,00012,00024,27017,981  
Debt      247
Other liabilities   27   
Due to related parties✕✕✕✕89  
Government assistance, liability6,422 ✕✕✕✕
Other undisclosed current liabilities2028357496821,017 
Total current liabilities:35,83721,02631,27023,5874,1332,971
Noncurrent Liabilities
Long-term debt and lease obligation   3,3763,3762,45371
Long-term debt, excluding current maturities   3,3763,376 71
Liabilities, other than long-term debt14,3203,9931,48711,346  
Deferred revenue    9,468  
Operating lease, liability14,3206161,4871,8782,453 
Government assistance, liability  3,376✕✕✕✕
Other undisclosed noncurrent liabilities     9243,376
Total noncurrent liabilities:14,3203,9934,86314,7225,8293,448
Total liabilities:50,15725,01936,13338,3099,9626,419
Equity
Equity, attributable to parent305,792145,46222,60111,78631,36828,200
Common stock574631252421
Additional paid in capital610,330344,224181,702148,735139,404116,217
Accumulated other comprehensive income (loss)2831,027236105  
Accumulated deficit(304,878)(199,835)(159,367)(137,080)(108,060)(88,038)
Total equity:305,792145,46222,60111,78631,36828,200
TOTAL LIABILITIES AND EQUITY:355,949170,48158,73450,09541,33034,619

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues4522,27025,1782,551245310
Other income45768191548 
Gross profit:4522,27025,1782,551245310
Operating expenses(108,142)(64,835)(49,256)(32,249)(21,183)(14,000)
Other undisclosed operating loss(45)     
Operating loss:(108,142)(42,565)(24,078)(29,697)(20,938)(13,690)
Nonoperating income3,1002,0981,79067891633
Investment income, nonoperating6,2582,2031,7295225733
Interest and debt expense (3,046)     
Other undisclosed loss from continuing operations before equity method investments, income taxes      
Loss from continuing operations before equity method investments, income taxes:(108,088)(40,4